Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Heinemann

Showing results (31-40 of 185) with videos related to

Pageof 19
Sort By:
Anticancer Research|January 1, 1989
Intermediate-dose Ara-C/m-AMSA for remission induction and high-dose Ara-C/m-AMSA for intensive consolidation in relapsed and refractory adult acute myelogenous leukemia (AML)U Jehn, V Heinemann, W Wilmanns
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2007
Leukocytoclastic vasculitis during treatment with the oral EGFR tyrosine kinase inhibitor erlotinibS Boeck, A Wollenberg, V Heinemann
MMW Fortschritte Der Medizin|November 15, 2000
[Locally advanced pancreatic carcinoma. Radiochemotherapy prolongs survival]R Wilkowski, V Heinemann, H Rau
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 16, 2013
Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancerV Heinemann, M Haas, S Boeck
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|December 19, 2007
Primary advanced unresectable pancreatic cancerR Wilkowski, M Wolf, V Heinemann
Leukemia & Lymphoma|September 1, 1995
Successful treatment of accelerated and blastic phase of chronic myeloid leukemia with high-dose interferon alpha and hydroxyurea: a novel approachU Jehn, C Pötscher, V Heinemann
Innere Medizin (Heidelberg, Germany)|August 4, 2022
[Treatment of metastatic pancreatic cancer]V Heinemann, S Boeck, C B Westphalen
Der Internist|January 9, 2014
[Chemotherapy of metastatic colorectal cancer]D P Modest, W Hiddemann, V Heinemann
Der Internist|November 26, 2010
[Multimodality treatment concepts for metastatic breast cancer]V Heinemann, S Kahlert, H-J Stemmler
Der Internist|July 29, 2011
[New tyrosine kinase and EGFR inhibitors in cancer therapy. Cardiac and skin toxicity as relevant side effects. Part B: Skin]L M Ehmann, V Heinemann, A Wollenberg
Pageof 19

Showing results (31-40 of 185) with videos related to

Sort By:
Pageof 19
Anticancer Research|January 1, 1989
Intermediate-dose Ara-C/m-AMSA for remission induction and high-dose Ara-C/m-AMSA for intensive consolidation in relapsed and refractory adult acute myelogenous leukemia (AML)U Jehn, V Heinemann, W Wilmanns
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2007
Leukocytoclastic vasculitis during treatment with the oral EGFR tyrosine kinase inhibitor erlotinibS Boeck, A Wollenberg, V Heinemann
MMW Fortschritte Der Medizin|November 15, 2000
[Locally advanced pancreatic carcinoma. Radiochemotherapy prolongs survival]R Wilkowski, V Heinemann, H Rau
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 16, 2013
Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancerV Heinemann, M Haas, S Boeck
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|December 19, 2007
Primary advanced unresectable pancreatic cancerR Wilkowski, M Wolf, V Heinemann
Leukemia & Lymphoma|September 1, 1995
Successful treatment of accelerated and blastic phase of chronic myeloid leukemia with high-dose interferon alpha and hydroxyurea: a novel approachU Jehn, C Pötscher, V Heinemann
Innere Medizin (Heidelberg, Germany)|August 4, 2022
[Treatment of metastatic pancreatic cancer]V Heinemann, S Boeck, C B Westphalen
Der Internist|January 9, 2014
[Chemotherapy of metastatic colorectal cancer]D P Modest, W Hiddemann, V Heinemann
Der Internist|November 26, 2010
[Multimodality treatment concepts for metastatic breast cancer]V Heinemann, S Kahlert, H-J Stemmler
Der Internist|July 29, 2011
[New tyrosine kinase and EGFR inhibitors in cancer therapy. Cardiac and skin toxicity as relevant side effects. Part B: Skin]L M Ehmann, V Heinemann, A Wollenberg
Pageof 19